Please contact us for more information or to learn if you are eligible to participate.
This is a randomized, open label, adaptive platform trial to compare the effectiveness of antithrombotic and additional treatment strategies for prevention of adverse outcomes in COVID-19 positive inpatients.
Olabiyi Akala, MD
Luis Cantu Jr.
National Center for Advancing Translation Sciences
Type of Trial